Literature DB >> 28232448

First Complete Genome Sequences of Zika Virus Isolated from Febrile Patient Sera in Ecuador.

S Márquez1, J Carrera1, S T Pullan2, K Lewandowski2, V Paz3, N Loman4, J Quick4, D Bonsall5, R Powell6, J Thézé7, O G Pybus7, P Klenerman5, J Eisenberg8, J Coloma9, M W Carroll2, G Trueba1, C H Logue10,2.   

Abstract

Here, we present the complete genome sequences of two Zika virus (ZIKV) strains, EcEs062_16 and EcEs089_16, isolated from the sera of febrile patients in Esmeraldas City, in the northern coastal province of Esmeraldas, Ecuador, in April 2016. These are the first complete ZIKV genomes to be reported from Ecuador.
Copyright © 2017 Márquez et al.

Entities:  

Year:  2017        PMID: 28232448      PMCID: PMC5323627          DOI: 10.1128/genomeA.01673-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The emergence and diagnostic detection of arthropod-borne viruses have been increasingly reported in Ecuador, and include dengue virus (DENV), chikungunya virus (CHIKV), and, most recently, Zika virus (ZIKV) (1). In 2016 alone, 2,693 suspected, 839 laboratory-confirmed, and 15 imported cases of ZIKV were reported (2). The early clinical manifestations resulting from infection with ZIKV closely resemble those caused by DENV and CHIKV (3), and without differential diagnosis by serological, molecular, or sequencing means, misdiagnosis based on clinical presentation alone may occur (4, 5). Here, we report the complete genome sequences of two ZIKV strains, EcEs062_16 and EcEs089_16, isolated from the sera of two febrile patients in the coastal province of Esmeraldas, Ecuador, in April 2016. ZIKV was detected in both patient sera samples using the Genesig Dengue, Zika and Chikungunya Virus Multiplex real-time assay kit on a BioRad CFX96 system, following the manufacturer’s guidelines (Genesig, United Kingdom). ZIKV was propagated from sera by inoculation of C6/36 cell monolayers (Aedes albopictus; ECACC, United Kingdom). Supernatant was removed after 7 days, purified, and nucleic acid extracted using the QIAamp viral RNA minikit (Qiagen Gmbl, Germany); 5 μl of purified RNA was used as template in ten 20-μL reactions, each with a set of 10 primer pairs designed to amplify ~1.5-kb overlapping amplicons covering the whole genome. Sample EcEs089_16 produced insufficient product from the 1.5-kb amplicon scheme, and therefore the 400-bp tiling amplicon protocol devised by Quick and Loman (http://www.zibraproject.org/data) was utilized to produce sufficient product for sequencing. Sequencing libraries were prepared from 1 μg of total material, comprising equimolar amounts of each of the 10 amplicons for EcEs062_16 or 500 ng of product from each of the two multiplex reactions for EcEs089_16. The Nanopore sequencing kit SQK-NSK007 (Oxford Nanopore Technologies, United Kingdom) was used to produce both sequencing libraries, according to the manufacturer’s R9 amplicon sequencing protocol. EcEs062_16 and EcEs089_16 libraries were sequenced on FLO_MIN104 and FLO_MIN105 flow cells, respectively. Sequencing was performed on an Mk1b MinION device. Bases were called in Metrichor using 2D Basecalling RNN for SQK-NSK007. Consensus sequences of 10,646 bp and 10,616 bp for EcEs062_16 and EcEs089_16, respectively, were generated using the ZiBRA analysis pipeline (http://www.zibraproject.org/data). Direct RNA sequencing of culture supernatant using Illumina technology provided fuller length sequences of 10,812 bp and 10,810 bp, respectively, for EcEs062_16 and EcEs089_16. The EcEs062_16 and EcEs089_16 genomes clustered together with a sequence isolated from Paraiba state, Brazil (KX280026, posterior probability 0.96, bootstrap support 75%), rather than with sequences from neighboring Colombia and Peru. Esmeraldas city is one of the furthest continental points west of the Paraiba region (4,874 km by air). Neither patient reported travel history to Brazil, and Ecuador does not share a land border with Brazil; therefore, the epidemiology of ZIKV’s introduction into and movement within Ecuador merits further investigation. We aim to further validate the potential of portable sequencing as a diagnostic tool to assess the temporal movements of ZIKV throughout South America, as we previously described for Ebola in West Africa (6).

Accession number(s).

The complete genomic sequences have been annotated and deposited in GenBank, under accession numbers KX879603 to KX879604, and on http://nextstrain.org/zika.
  4 in total

1.  Dengue, chikungunya and Zika co-infection in a patient from Colombia.

Authors:  Wilmer E Villamil-Gómez; Orfy González-Camargo; José Rodriguez-Ayubi; Diana Zapata-Serpa; Alfonso J Rodriguez-Morales
Journal:  J Infect Public Health       Date:  2016-01-03       Impact factor: 3.718

Review 2.  Zika virus, vectors, reservoirs, amplifying hosts, and their potential to spread worldwide: what we know and what we should investigate urgently.

Authors:  Rengina Vorou
Journal:  Int J Infect Dis       Date:  2016-05-18       Impact factor: 3.623

3.  Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador.

Authors:  Stephen R Manock; Kathryn H Jacobsen; Narcisa Brito de Bravo; Kevin L Russell; Monica Negrete; James G Olson; José L Sanchez; Patrick J Blair; Roger D Smalligan; Brad K Quist; Juan Freire Espín; Willan R Espinoza; Fiona MacCormick; Lila C Fleming; Tadeusz Kochel
Journal:  Am J Trop Med Hyg       Date:  2009-07       Impact factor: 2.345

4.  Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.

Authors:  Miles W Carroll; David A Matthews; Julian A Hiscox; Michael J Elmore; Georgios Pollakis; Andrew Rambaut; Roger Hewson; Isabel García-Dorival; Joseph Akoi Bore; Raymond Koundouno; Saïd Abdellati; Babak Afrough; John Aiyepada; Patience Akhilomen; Danny Asogun; Barry Atkinson; Marlis Badusche; Amadou Bah; Simon Bate; Jan Baumann; Dirk Becker; Beate Becker-Ziaja; Anne Bocquin; Benny Borremans; Andrew Bosworth; Jan Peter Boettcher; Angela Cannas; Fabrizio Carletti; Concetta Castilletti; Simon Clark; Francesca Colavita; Sandra Diederich; Adomeh Donatus; Sophie Duraffour; Deborah Ehichioya; Heinz Ellerbrok; Maria Dolores Fernandez-Garcia; Alexandra Fizet; Erna Fleischmann; Sophie Gryseels; Antje Hermelink; Julia Hinzmann; Ute Hopf-Guevara; Yemisi Ighodalo; Lisa Jameson; Anne Kelterbaum; Zoltan Kis; Stefan Kloth; Claudia Kohl; Miša Korva; Annette Kraus; Eeva Kuisma; Andreas Kurth; Britta Liedigk; Christopher H Logue; Anja Lüdtke; Piet Maes; James McCowen; Stéphane Mély; Marc Mertens; Silvia Meschi; Benjamin Meyer; Janine Michel; Peter Molkenthin; César Muñoz-Fontela; Doreen Muth; Edmund N C Newman; Didier Ngabo; Lisa Oestereich; Jennifer Okosun; Thomas Olokor; Racheal Omiunu; Emmanuel Omomoh; Elisa Pallasch; Bernadett Pályi; Jasmine Portmann; Thomas Pottage; Catherine Pratt; Simone Priesnitz; Serena Quartu; Julie Rappe; Johanna Repits; Martin Richter; Martin Rudolf; Andreas Sachse; Kristina Maria Schmidt; Gordian Schudt; Thomas Strecker; Ruth Thom; Stephen Thomas; Ekaete Tobin; Howard Tolley; Jochen Trautner; Tine Vermoesen; Inês Vitoriano; Matthias Wagner; Svenja Wolff; Constanze Yue; Maria Rosaria Capobianchi; Birte Kretschmer; Yper Hall; John G Kenny; Natasha Y Rickett; Gytis Dudas; Cordelia E M Coltart; Romy Kerber; Damien Steer; Callum Wright; Francis Senyah; Sakoba Keita; Patrick Drury; Boubacar Diallo; Hilde de Clerck; Michel Van Herp; Armand Sprecher; Alexis Traore; Mandiou Diakite; Mandy Kader Konde; Lamine Koivogui; N'Faly Magassouba; Tatjana Avšič-Županc; Andreas Nitsche; Marc Strasser; Giuseppe Ippolito; Stephan Becker; Kilian Stoecker; Martin Gabriel; Hervé Raoul; Antonino Di Caro; Roman Wölfel; Pierre Formenty; Stephan Günther
Journal:  Nature       Date:  2015-06-17       Impact factor: 49.962

  4 in total
  1 in total

1.  Isolation of Oropouche Virus from Febrile Patient, Ecuador.

Authors:  Emma L Wise; Steven T Pullan; Sully Márquez; Verónica Paz; Juan D Mosquera; Sonia Zapata; Simon K Jackson; Gyorgy Fejer; Gabriel Trueba; Christopher H Logue
Journal:  Emerg Infect Dis       Date:  2018-05       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.